Skip to main content
. 2022 Mar 28;2022:5129314. doi: 10.1155/2022/5129314

Table 3.

Based on organic complications in survive and nonsurvive patients.

Variable Survived n = 90 Nonsurvived n = 114 P value
Kidney, n (%) 20 (22.2) 87 (76.3) ≤0.001
 AKI 14 (15.6) 73 (64) ≤0.001
 Uremia 20 (22.2) 82 (71.9) ≤0.001
 Oliguria 0 9 (7.9) NA
 Anuria 0 5 (4.4) NA
 Dialysis 1 (5) 15 (17.2) 0.001
Liver, n (%) 26 (28.9) 41 (36) 0.298
 ↑ Enzyme 23 (25.6) 25 (21.9) 0.619
 Bilirubinemia 17 (18.9) 28 (24.6) 0.396
 Coagulopathy 2 (2.2) 28 (24.6) ≤0.001
Hematologic, n (%) 78 (86.7) 104 (91.2) 0.365
 Thrombocytopenia 6 (6.7) 24 (21.1) ≤0.001
 Leukocytosis 36 (40) 66 (57.9) 0.016
 Lymphopenia 69 (76.6) 103 (90.4) 0.017
 Anemia 18 (20) 40 (35.1) 0.020
Heart, n (%) 3 (3.3) 70 (61.4) ≤0.001
 ↓ EF ≤40% 3 (3.3) 4 (3.5) 0.629
 Vasopressor 1 (1.1) 70 (61.4) ≤0.001
 Inotrope 1 (1.1) 13 (11.4) 0.001
Neurologic, n (%) 2 (2.2) 15 (13.2) 0.005
 Loss of consciousness 0 10 (8.8) NA
 Seizure 0 0 NA
 Lethargy 0 2 (1.8) NA
 Delirium 2 (2.2) 5 (4.9) 0.468
 Paresthesia/plegia 0 1 (0.9) NA
GI, n (%) 8 (44.4) 3 (50) 0.063
 Bleeding 4 (22.2) 1 (16.6) 0.172
 Diarrhea 4 (22.2) 2 (33.3) 0.409
 Melena 2 (11.1) 0 NA
Respiratory, n (%) 2 (66.6) 23 (45.1) ≤0.001
 Hemoptysis 0 6 (11.7) NA
 Pneumothorax 0 10 (19.6) NA
 Emphysema 0 5 (9.8) NA
 Effusion 1 (33.4) 7 (13.7) 0.080

AKI: acute kidney injury, EF: ejection fraction, GI: gastrointestinal, and NA: not applicable.